[1]
F. Gärtner, J. Aßmus, Øystein Fløtten, M. Paula Ramnefjell, and M. Aanerud, “Characteristics and survival of patients with non-small cell lung cancer treated with immune-checkpoint inhibitors in the real-world: experiences from Bergen, Norway”, AO, vol. 61, no. 7, pp. 814–818, Jul. 2022.